tomeko

TMEM165-congenital disorder of glycosylation

Just diagnosed with TMEM165-congenital disorder of glycosylation?

You are not alone. Here is where to start: learn the basics, find a specialist or center that sees TMEM165-congenital disorder of glycosylation, look for clinical trials, and connect with others living with it — all in one place.

Open the full TMEM165-congenital disorder of glycosylation hub →

Overview

TMEM165-congenital disorder of glycosylation is a rare condition. Also known as Carbohydrate deficient glycoprotein syndrome type IIk, Congenital disorder of glycosylation type 2k, Congenital disorder of glycosylation type IIk, CDG syndrome type IIk, CDG-IIk, CDG2K. Tomeko brings together the specialists, research, clinical trials, treatments and community for TMEM165-congenital disorder of glycosylation so you can go from overwhelmed to oriented. For authoritative medical detail, see the reference sources below.

Identifiers: ORPHA:314667 · OMIM 614727 · ICD-10 E77.8 · GARD 0012413

Find care for TMEM165-congenital disorder of glycosylation

Authoritative references for TMEM165-congenital disorder of glycosylation

Common questions

I was just diagnosed with TMEM165-congenital disorder of glycosylation — what should I do first?

Start by learning the basics from an authoritative source, find a specialist or center that sees TMEM165-congenital disorder of glycosylation, and connect with a patient organization. Tomeko brings these together on one hub.

Where can I find a specialist for TMEM165-congenital disorder of glycosylation?

Use Tomeko's specialist and Centers-of-Excellence directories to find clinicians who treat TMEM165-congenital disorder of glycosylation, filtered to your area.

Are there clinical trials for TMEM165-congenital disorder of glycosylation?

Tomeko shows live, recruiting studies for TMEM165-congenital disorder of glycosylation from ClinicalTrials.gov on the hub.

Informational only — not medical advice. Always consult a qualified clinician. Provider and reference data from public sources (NIH GARD, Orphanet, OMIM, HPO, MONDO, ClinicalTrials.gov, CMS NPPES). © Tomeko · tomekohealth.com